WallStreetZenWallStreetZen

NASDAQ: CELC
Celcuity Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CELC

Based on 7 analysts offering 12 month price targets for Celcuity Inc

Min Forecast
$140.00+67.77%
Avg Forecast
$162.00+94.13%
Max Forecast
$177.00+112.1%

Should I buy or sell CELC stock?

Based on 7 analysts offering ratings for Celcuity Inc.

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
4 analysts 57.14%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CELC's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CELC as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -12.86% per year. Learn More

Be the first to know when Wall Street analysts revise their CELC stock forecasts and price targets.

CELC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-17Find Out Why
lockedlocked$00.00+00.00%2026-08-17
lockedlocked$00.00+00.00%2026-08-14
lockedlocked$00.00+00.00%2026-08-14
lockedlocked$00.00+00.00%2026-08-14
Craig-Hallum
Bottom 5%
5
BuyMaintains$171.00+104.91%2026-06-03
Wells Fargo
Top 5%
96
Strong BuyMaintains$166.00+98.92%2026-06-03

1 of 1

Forecast return on equity

Is CELC forecast to generate an efficient return?

Company
-4,748.55%
Industry
20.5%
Market
167.71%
CELC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CELC forecast to generate an efficient return on assets?

Company
73.28%
Industry
23.66%
CELC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CELC earnings per share forecast

What is CELC's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
-$4.49
Avg 2 year Forecast
-$0.83
Avg 3 year Forecast
$3.35

CELC revenue forecast

What is CELC's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$39.9M
Avg 2 year Forecast
$434.7M
Avg 3 year Forecast
$783.3M

CELC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELC$83.45$162.00+94.13%Strong Buy
MANE$98.97$150.17+51.73%Strong Buy
RLAY$18.87$25.91+37.30%Strong Buy
TNGX$23.78$46.10+93.86%Strong Buy
ELVN$54.32$75.00+38.07%Strong Buy
View Top Biotech Stocks

Celcuity Stock Forecast FAQ

Is Celcuity Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: CELC) stock is to Strong Buy CELC stock.

Out of 7 analysts, 3 (42.86%) are recommending CELC as a Strong Buy, 4 (57.14%) are recommending CELC as a Buy, 0 (0%) are recommending CELC as a Hold, 0 (0%) are recommending CELC as a Sell, and 0 (0%) are recommending CELC as a Strong Sell.

If you're new to stock investing, here's how to buy Celcuity stock.

What is CELC's earnings growth forecast for 2026-2028?

(NASDAQ: CELC) Celcuity's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.8%.

Celcuity's earnings in 2026 is -$226,482,000.On average, 13 Wall Street analysts forecast CELC's earnings for 2026 to be -$219,787,451, with the lowest CELC earnings forecast at -$261,345,321, and the highest CELC earnings forecast at -$183,421,257. On average, 13 Wall Street analysts forecast CELC's earnings for 2027 to be -$40,520,513, with the lowest CELC earnings forecast at -$145,298,408, and the highest CELC earnings forecast at $117,142,988.

In 2028, CELC is forecast to generate $163,985,503 in earnings, with the lowest earnings forecast at $11,508,785 and the highest earnings forecast at $307,243,450.

What is CELC's revenue growth forecast for 2026-2028?

(NASDAQ: CELC) Celcuity's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.

Celcuity's revenue in 2026 is $0.On average, 12 Wall Street analysts forecast CELC's revenue for 2026 to be $1,954,731,861, with the lowest CELC revenue forecast at $479,532,698, and the highest CELC revenue forecast at $4,033,848,632. On average, 12 Wall Street analysts forecast CELC's revenue for 2027 to be $21,270,700,408, with the lowest CELC revenue forecast at $9,883,266,778, and the highest CELC revenue forecast at $35,502,545,849.

In 2028, CELC is forecast to generate $38,329,831,494 in revenue, with the lowest revenue forecast at $20,859,672,380 and the highest revenue forecast at $63,317,888,952.

What is CELC's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CELC) forecast ROA is 73.28%, which is higher than the forecast US Biotechnology industry average of 23.66%.

What is CELC's Price Target?

According to 7 Wall Street analysts that have issued a 1 year CELC price target, the average CELC price target is $162.00, with the highest CELC stock price forecast at $177.00 and the lowest CELC stock price forecast at $140.00.

On average, Wall Street analysts predict that Celcuity's share price could reach $162.00 by Aug 17, 2027. The average Celcuity stock price prediction forecasts a potential upside of 94.13% from the current CELC share price of $83.45.

What is CELC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CELC) Celcuity's current Earnings Per Share (EPS) is -$4.31. On average, analysts forecast that CELC's EPS will be -$4.49 for 2026, with the lowest EPS forecast at -$5.34, and the highest EPS forecast at -$3.75. On average, analysts forecast that CELC's EPS will be -$0.83 for 2027, with the lowest EPS forecast at -$2.97, and the highest EPS forecast at $2.39. In 2028, CELC's EPS is forecast to hit $3.35 (min: $0.24, max: $6.28).

What is CELC's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CELC) forecast ROE is -4,748.55%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.